Skip to main content
Caplight Logo









dEEGtal Insight

dEEGtal Insight

Private
GenevaHealthcare & Life Scienceshttps://www.deegtal.ai/

Last Round

Grant

Sep 23, 2025

Total Funding Raised

$1.85M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

dEEGtal Insight is a medical technology company that provides AI-powered software to enhance and accelerate the diagnosis of epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

epilepsy diagnosisEEG analysisAI diagnosticsmedical AIepilepsy risk scoremedtechdiagnostic softwareclinical decision supportelectroencephalogram analysisEEGneurology softwareautomated EEG interpretationclinical workflow integrationprecision medicinedigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

dEEGtal Insight Comparables

Compare dEEGtal Insight with similar companies based on industry and business-model similarity.

dEEGtal Insight comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Piramidal
81%
Persyst Development Corporation
74%
AIT Austrian Institute of Technology
74%

dEEGtal Insight Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 23, 2025
SeedDec 13, 2024
GrantAug 26, 2024

Key People

Founding team and executive leadership

Eric Ménétré

CEO & Co-Founder

Founding Team

dEEGtal Insight Investors

Notable investors and investment history

dEEGtal Insight investors
InvestorRounds
Wyss Center for Bio and NeuroengineeringSeed
InnosuisseGrant
Venture KickGrant, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2025

    $704K grant received from Innosuisse.

  • Dec 13, 2024

    $1.1M round led by Wyss Center for Bio and Neuroengineering

dEEGtal Insight Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

dEEGtal Insight Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about dEEGtal Insight's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeneva
Employee Range6
Year Founded2024
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?